Company intelligence / Profile preview

Develco Pharma

Pratteln, Basel-Landschaft, Switzerlanddevelco.ch ↗

Ownership: Private
Employees: ~49
Development stage: Commercial

Overview

Develco Pharma develops and manufactures innovative modified-release formulations of drugs with established active ingredients. The company focuses on improving patient quality of life through advanced drug delivery technologies. Its main therapeutic areas are severe pain management and ADHD. Products are licensed to international pharmaceutical partners after approval. Patent filings indicate work in analgesics and antidepressants. No detailed clinical trial results are publicly available.

Therapeutic areas: PsychiatryNeurology
Modalities: Small moleculeModified release formulationExtended release formulation
Industry: Biotech

Partnerships

International pharmaceutical companies via outlicensing agreements; specific partners not named publicly.

Beyond the preview

Go deeper on Develco Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Develco Pharma.

Explore the full profile